Literature DB >> 14769792

Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells.

Susumu Mitsutake1, Tack-Joong Kim, Yuichi Inagaki, Mariko Kato, Toshiyuki Yamashita, Yasuyuki Igarashi.   

Abstract

Ceramide kinase (CERK) catalyzes the conversion of ceramide to ceramide 1-phosphate (C1P) and is known to be activated by calcium. Although several groups have examined the functions of CERK and its product C1P, the functions of C1P and CERK are not understood. We studied the RBL-2H3 cell line, a widely used model for mast cells, and found that CERK and C1P are required for activation of the degranulation process in mast cells. We found that C1P formation was enhanced during activation induced by IgE/antigen or by Ca(2+) ionophore A23187. The formation of C1P required the intracellular elevation of Ca(2+). We generated RBL-2H3 cells that stably express CERK, and when these cells were treated with A23187, a concomitant C1P formation was observed and degranulation increased 4-fold, compared with mock transfectants. The cell-permeable N-acetylsphingosine (C(2)-ceramide), a poor substrate of CERK, inhibited both the formation of C1P and degranulation, indicating that C1P formation was necessary for degranulation. Exogenous introduction of CERK into permeabilized RBL-2H3 cells caused degranulation. We identified a cytosolic localization of CERK that provides exposure to cytosolic Ca(2+). Taken together, these results indicate that C1P formation is a necessary step in the degranulation pathway in RBL-2H3 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769792     DOI: 10.1074/jbc.M312885200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  A critical beta6-beta7 loop in the pleckstrin homology domain of ceramide kinase.

Authors:  Philipp Rovina; Markus Jaritz; Siegfried Höfinger; Christine Graf; Piroska Dévay; Andreas Billich; Thomas Baumruker; Frédéric Bornancin
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

Review 2.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  C(6)-ceramide enhances phagocytic activity of Kupffer cells through the production of endogenous ceramides.

Authors:  Jong Min Choi; So Jung Chu; Kyong Hoon Ahn; Seok Kyun Kim; Jung Eun Ji; Jong Hoon Won; Hyung Chul Kim; Moon Jung Back; Dae Kyong Kim
Journal:  Mol Cells       Date:  2011-08-25       Impact factor: 5.034

Review 4.  Ceramide-1-phosphate in phagocytosis and calcium homeostasis.

Authors:  Vania Hinkovska-Galcheva; James A Shayman
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Chain length specificity for activation of cPLA2alpha by C1P: use of the dodecane delivery system to determine lipid-specific effects.

Authors:  Dayanjan S Wijesinghe; Preeti Subramanian; Nadia F Lamour; Luciana B Gentile; Maria H Granado; Alicja Bielawska; Zdzislaw Szulc; Antonio Gomez-Munoz; Charles E Chalfant
Journal:  J Lipid Res       Date:  2008-12-15       Impact factor: 5.922

6.  A fluorescent plate reader assay for ceramide kinase.

Authors:  Anthony S Don; Hugh Rosen
Journal:  Anal Biochem       Date:  2007-12-25       Impact factor: 3.365

7.  Ceramide kinase expression is altered during macrophage-like cell differentiation of the leukemia cell line HL-60.

Authors:  Tomomi Date; Susumu Mitsutake; Yasuyuki Igarashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-10-24       Impact factor: 2.416

Review 8.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

Review 9.  Twenty-first century mast cell stabilizers.

Authors:  D F Finn; J J Walsh
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

10.  Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice.

Authors:  Satoru Niwa; Nicole Urtz; Thomas Baumruker; Andreas Billich; Frédéric Bornancin
Journal:  Lipids Health Dis       Date:  2010-01-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.